US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

35.30

-0.5372-1.50%

Volume:6K

Turnover:210.20K

Market Cap:1.59M

PE:- -

High:35.45

Open:35.04

Low:35.04

Close:35.84

52wk High:35.84

52wk Low:23.88

Shares:45.00K

Float Shares:45.00K

Volume Ratio:5.06

T/O Rate:13.25%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Corgi Genomics & Precision Medicine ETF

Exchange:

CBOE

Establishment Date:

2026

Employees:

- -

Office Location:

425 Bush Street,Suite 500,San Francisco,California,United States

Website:

http://www.medgenics.com

Zip Code:

94108-3726

Phone:

Fax:

- -

Introduction:

Aevi Genomic Medicine, Inc., a clinical stage medical technology company, engages in the research and development of products in the field of biotechnology and associated medical equipment in the United States. The company develops transduced autologous restorative gene therapy (TARGT), a platform to provide protein and peptide therapies to treat a range of chronic diseases. Its lead product candidate is MDGN-201, which is an endogenous erythropoietin secretion TARGT that is in the Phase I/II clinical trials for the treatment of end stage renal diseases and other indications, including ß-thalassemia. The company was formerly known as Medgenics, Inc. and changed its name to Aevi Genomic Medicine, Inc. in December 2016. Aevi Genomic Medicine, Inc. was founded in 2000 and is based in Wayne, Pennsylvania.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GNMX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":35.3,"timestamp":1787593676307,"preClose":35.8372,"halted":0,"volume":5964,"delay":0,"changeRate":-0.014990010380275401,"floatShares":45000,"shares":45000,"eps":0,"marketStatus":"Trading","change":-0.5372,"latestTime":"08-24 13:48:45 EDT","open":35.035,"high":35.45,"low":35.035,"amount":210200.05876800002,"amplitude":0.01158,"askPrice":35.35,"askSize":1100,"bidPrice":35.11,"bidSize":1100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":35.8372,"nav":35.12,"aum":1580400,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.82,"preClose":35.8372,"latestTime":"16:10 EDT","volume":6,"amount":215.0232,"timestamp":1787343004158,"change":-0.0172,"changeRate":-0.00048,"amplitude":0},"volumeRatio":5.05946,"impliedVol":0.1803,"impliedVolPercentile":0.3582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":45000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":5.05946,"shares":45000,"dividePrice":0,"high":35.45,"amplitude":0.01158,"preClose":35.8372,"low":35.035,"week52Low":23.88,"pbRate":"--","week52High":35.8439,"institutionHeld":0,"latestPrice":35.3,"eps":0,"divideRate":0,"volume":5964,"delay":0,"ttmEps":0,"open":35.035,"prevYearClose":25.56,"prevWeekClose":35.8372,"prevMonthClose":29.7248,"prevQuarterClose":31.0879,"fiveDayClose":32.3271,"twentyDayClose":29.7525,"sixtyDayClose":26.8115},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1992790800,"yearFounded":2026,"address":"425 Bush Street,Suite 500,San Francisco,California,United States","zipCode":"94108-3726","officePhone":"855 552 6744"},"stockCompanyDetail":{"websiteUrl":"http://www.medgenics.com","stockEarnings":[{"period":"1week","weight":0.122},{"period":"1month","weight":0.2121},{"period":"3month","weight":0.4185},{"period":"6month","weight":0.4021},{"period":"ytd","weight":0.4021}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aevi Genomic Medicine, Inc., a clinical stage medical technology company, engages in the research and development of products in the field of biotechnology and associated medical equipment in the United States. The company develops transduced autologous restorative gene therapy (TARGT), a platform to provide protein and peptide therapies to treat a range of chronic diseases. Its lead product candidate is MDGN-201, which is an endogenous erythropoietin secretion TARGT that is in the Phase I/II clinical trials for the treatment of end stage renal diseases and other indications, including ß-thalassemia. The company was formerly known as Medgenics, Inc. and changed its name to Aevi Genomic Medicine, Inc. in December 2016. Aevi Genomic Medicine, Inc. was founded in 2000 and is based in Wayne, Pennsylvania.","exchange":"CBOE","name":"Corgi Genomics & Precision Medicine ETF","nameEN":"Corgi Genomics & Precision Medicine ETF"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":null}}